Home
Search
Study Topics
Glossary
|
|
|
|
|
|
Sponsored by: |
Biogen Idec |
---|---|
Information provided by: | Biogen Idec |
ClinicalTrials.gov Identifier: | NCT00575068 |
The purpose of this study is to determine whether anti-CD80 monoclonal antibody (IDEC-114) is effective in the treatment of follicular B-cell non-Hodgkin's lymphoma. This drug has never been studied in patients with lymphoma, however, it has been studied in psoriasis patients at various dose levels and schedules.
Condition | Intervention | Phase |
---|---|---|
Non-Hodgkin's Lymphoma |
Drug: IDEC-114 |
Phase I Phase II |
Study Type: | Interventional |
Study Design: | Treatment, Non-Randomized, Open Label, Uncontrolled, Safety/Efficacy Study |
Official Title: | A Phase I/II Trial of Anti-CD80 Monoclonal Antibody (IDEC-114) Therapy for Patients With Relapsed or Refractory Follicular Lymphoma |
Ages Eligible for Study: | 18 Years and older |
Genders Eligible for Study: | Both |
Accepts Healthy Volunteers: | No |
Inclusion Criteria:
Exclusion Criteria:
United States, Arizona | |
Arizona Cancer Center/University of Arizona | |
Tucson, Arizona, United States, 85724 | |
United States, Minnesota | |
Mayo Clinic | |
Rochester, Minnesota, United States, 55902 | |
United States, New York | |
Roswell Park Cancer Institute, Department of Medicine | |
Buffalo, New York, United States, 14263 | |
United States, North Carolina | |
Duke University Medical Center, Morris Cancer Center | |
Durham, North Carolina, United States, 27710 |
Study Director: | Biogen Idec | Biogen Idec |
Responsible Party: | Biogen Idec ( Biogen Idec MD ) |
Study ID Numbers: | 114-20 |
Study First Received: | December 13, 2007 |
Last Updated: | December 13, 2007 |
ClinicalTrials.gov Identifier: | NCT00575068 |
Health Authority: | United States: Food and Drug Administration |
Antibodies, Monoclonal Lymphatic Diseases Antibodies Immunoproliferative Disorders Lymphoma, small cleaved-cell, diffuse Lymphoma, Follicular |
Lymphoproliferative Disorders Lymphoma, Non-Hodgkin Lymphoma Follicular lymphoma Immunoglobulins |
Neoplasms Neoplasms by Histologic Type Immune System Diseases |